Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. New Zealand
  4. New Zealand Stock Exchange
  5. TruScreen Group Limited
  6. News
  7. Summary
    TRU   NZTRUE0001S7


End-of-day quote. End-of-day quote New Zealand Stock Exchange - 08/03
0.064 NZD   0.00%
07/08TRUSCREEN : Director Nominations Closing Date
07/01TRUSCREEN : First Sales Made in Eastern Europe
06/30TRUSCREEN : to Ship Cervical Cancer Screening Devices to Serbia in July
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

TruScreen : Application for Dual Listing of TruScreen Shares on ASX

11/08/2020 | 05:00pm EDT
Cervical cancer screening technology company, TruScreen Group Limited (NZX: TRU) advises that it intends to undertake a capital raising initiative, by way of a public offer, to raise up to a maximum of NZD$2 million ('Offer') in conjunction with the dual listing of its shares on the ASX.An application will shortly be made to ASX, after the Product Disclosure Statement ('PDS') in support of the Offer has been lodged on the Offer Register, for TruScreen to be admitted to the Official List of ASX as an ASX Foreign Exempt Listing and for quotation of the new shares to be offered in Australia on the ASX. If TruScreen is admitted to the official list of ASX, then those Australian based investors in the Offer will have their Shares quoted on the ASX.

Purpose of the Offer

The purpose of the Offer is to raise not less than NZ$1.0 million and not more than NZ$ 2 million of new capital through the issue of up to a maximum of 28,571,428 million new ordinary fully paid shares in TruScreen at an issue price of NZD 7 cents (AUD 6.5 cents).

The money raised under the Offer will be applied towards the following initiatives:
• Investment in team capabilities for business expansion;
• Establish device manufacturing in China for Chinese operations;
• Reduce the cost of the product via R&D initiatives;
• Market development through market access/medical affairs capability;
• Costs associated with the Offer and dual listing; and
• General working capital.

This Offer is conditional upon the ASX approving the admission of the Company to the Official List of the ASX as an ASX Foreign Exempt Listing and for quotation of the Shares on the ASX on or before that Closing Date (as that date may be varied from time to time). In the event that this condition is not satisfied, then this Offer will not proceed, and all application moneys received by the Company will be refunded to investors in full and without deduction within 5 business days.

Key terms of the offer

Description of securities being offered Ordinary fully paid shares

Price NZD 7 cents per Share, or AUD 6.5 cents per Share

Intended Opening Date of the Offer 26 November 2020

Intended Closing Date 18 December 2020

Number or amount of the equity securities being offered The Offer has been divided in to two geographic pools. A pool of 14,285,714 new Shares ($NZD1 million) has been set aside for subscription by Australian Residents ('Australian Pool'). A pool of 7,142,857 new Shares (NZD$500,000) has been set aside for subscription by New Zealand Residents ('NZ Pool').

In the event that one of the geographic pools is undersubscribed, then the balance of that pool may be allocated to the other pool for subscription.

The Board of TruScreen has the discretion to accept oversubscriptions of up to a maximum of 7,142,857 new Shares representing a maximum of $500,000. In the event that the Offer is fully subscribed and the Board resolves to accept oversubscriptions to the maximum level of NZ$2,000,000, the maximum number of Shares that can be offered under the Offer is 28,571,428 Shares.

Any oversubscriptions received shall be apportioned as between the two geographic pools referred to above, in the same proportions as each of the two geographic pools represent, as a percentage of the total Offer.

Scaling TruScreen may scale applications at its sole discretion.

The above dates are subject to change at the discretion of the Board of TruScreen, subject to compliance with NZX Listing Rules and ASX and ASIC requirements.

A copy of the PDS and collateral information will be released to the market once the PDS has been finalised and registered on the Offer Register in New Zealand.

TruScreen will advise the market once it has received confirmation from the ASX that its application for admission to the Official List on the ASX has been approved, and the Offer is unconditional.

Truscreen is being advised, in New Zealand, by CM Partners Limited.


Intention To Make Application For Dual Listing Of Truscreen's Shares On The ASX.PDF


TruScreen Limited published this content on 09 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 November 2020 21:59:02 UTC

ę Publicnow 2020
07/08TRUSCREEN : Director Nominations Closing Date
07/01TRUSCREEN : First Sales Made in Eastern Europe
06/30TRUSCREEN : to Ship Cervical Cancer Screening Devices to Serbia in July
06/01TRUSCREEN : FY21 Preliminary Results
03/24TRUSCREEN : Research Confirms TruSreeen Suitability in COVID-19 Environment
03/23TRUSCREEN : Cervical Cancer Screening Device Suitable for COVID-19 Environment
03/01TRUSCREEN : Board Appointment
03/01TruScreen Group Limited Announces Board Changes
02/25TRUSCREEN : Executive Leadership Change
02/25TruScreen Group Limited Announces Executive Changes
More news
Sales 2021 1,97 M 1,39 M 1,39 M
Net income 2021 -3,49 M -2,45 M -2,45 M
Net cash 2021 5,26 M 3,69 M 3,69 M
P/E ratio 2021 -9,18x
Yield 2021 -
Capitalization 23,2 M 16,3 M 16,3 M
EV / Sales 2020 6,02x
EV / Sales 2021 15,5x
Nbr of Employees -
Free-Float 69,8%
Duration : Period :
TruScreen Group Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Mean consensus -
Number of Analysts
Last Close Price 0,06 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Juliet Hull Chief Executive Officer & Director
Guy Robertson Chief Financial Officer & Secretary
Peng Ho Non-Executive Chairman
Edmond Capcelea Chief Technology Officer
Nicole Melia Manager-Administration & Marketing
Sector and Competitors